Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Niendorf

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cell Communication and Signaling : CCS|August 29, 2019
Immature O-glycans recognized by the macrophage glycoreceptor CLEC10A (MGL) are induced by 4-hydroxy-tamoxifen, oxidative stress and DNA-damage in breast cancer cellsAnna-Katharina Kurze, Sophia Buhs, Dennis Eggert, et al.
Journal of Biophotonics|January 27, 2012
A compartment-specific transcriptome analysis reveals survival-relevant marker genes in the stroma fraction of squamous non-small cell lung cancerKlaus Bendrat, Axel Stang, Georgi Georgiev, et al.
Medical & Biological Engineering & Computing|February 1, 2012
Sensor-based cell and tissue screening for personalized cancer chemotherapyRegina Kleinhans, Martin Brischwein, Pei Wang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 2013
Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissuesPeter Nollau, Gerrit Wolters-Eisfeld, Naghmeh Mortezai, et al.
Anticancer Research|July 29, 2016
Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone ReceptorKlaus Bendrat, Peter Fritz, Simon Müller, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, <i>MKI67</i>, and a Novel Proliferation SignatureAnne-Sophie Wegscheider, Joanna Gorniak, Sara Rollinson, et al.
Microscopy Research and Technique|December 22, 2016
Outlook on optimizing ultramicroscopy imaging technique through optical characterizationSaiedeh Saghafi, Klaus Becker, Christian Hahn, et al.
Glycobiology|January 11, 2024
CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypesAnne-Sophie Wegscheider, Irina Wojahn, Pablo Gottheil, et al.
Anticancer Research|July 2, 2014
Tubular breast cancer. A retrospective studyPeter Fritz, Klaus Bendrat, Maike Sonnenberg, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell Communication and Signaling : CCS|August 29, 2019
Immature O-glycans recognized by the macrophage glycoreceptor CLEC10A (MGL) are induced by 4-hydroxy-tamoxifen, oxidative stress and DNA-damage in breast cancer cellsAnna-Katharina Kurze, Sophia Buhs, Dennis Eggert, et al.
Journal of Biophotonics|January 27, 2012
A compartment-specific transcriptome analysis reveals survival-relevant marker genes in the stroma fraction of squamous non-small cell lung cancerKlaus Bendrat, Axel Stang, Georgi Georgiev, et al.
Medical & Biological Engineering & Computing|February 1, 2012
Sensor-based cell and tissue screening for personalized cancer chemotherapyRegina Kleinhans, Martin Brischwein, Pei Wang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 2013
Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissuesPeter Nollau, Gerrit Wolters-Eisfeld, Naghmeh Mortezai, et al.
Anticancer Research|July 29, 2016
Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone ReceptorKlaus Bendrat, Peter Fritz, Simon Müller, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
Comprehensive and Accurate Molecular Profiling of Breast Cancer through mRNA Expression of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, <i>MKI67</i>, and a Novel Proliferation SignatureAnne-Sophie Wegscheider, Joanna Gorniak, Sara Rollinson, et al.
Microscopy Research and Technique|December 22, 2016
Outlook on optimizing ultramicroscopy imaging technique through optical characterizationSaiedeh Saghafi, Klaus Becker, Christian Hahn, et al.
Glycobiology|January 11, 2024
CD301 and LSECtin glycan-binding receptors of innate immune cells serve as prognostic markers and potential predictors of immune response in breast cancer subtypesAnne-Sophie Wegscheider, Irina Wojahn, Pablo Gottheil, et al.
Anticancer Research|July 2, 2014
Tubular breast cancer. A retrospective studyPeter Fritz, Klaus Bendrat, Maike Sonnenberg, et al.
Pageof 2